References
- Hofman M, Ryan JL, Figueroa-Moseley CD, et al. Cancer-related fatigue: the scale of the problem. Oncologist 2007;12(1 Suppl):4–10
- Kimel M, Leidy NK, Mannix S, et al. Does epoetin alfa improve health-related quality of life in chronically ill patients with anemia? Summary of trials of cancer, HIV/AIDS, and chronic kidney disease. Value Health 2008;11:57–75
- Cella D, Kallich J, McDermott A, et al. The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from five randomized clinical trials. Ann Oncol 2004;15:979–86
- Cremieux PY, Finkelstein SN, Berndt ER, et al. Cost effectiveness, quality-adjusted life-years and supportive care. Recombinant human erythropoietin as a treatment of cancer-associated anaemia. Pharmacoeconomics 1999;16:459–72
- Bokemeyer C, Aapro MS, Courdi A, et al. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update. Eur J Cancer 2007;43:258–70
- Rizzo JD, Seidenfeld J, Piper M, et al. Erythropoietin: a paradigm for the development of practice guidelines. Hematology Am Soc Hematol Educ Program 2001;10–30
- Hedenus M, Adriansson M, San MJ, et al. Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study. Br J Haematol 2003;122:394–403
- Esquerdo G, Llorca C, Cervera JM, et al. Effectiveness of darbepoetin alfa in a cohort of oncology patients with chemotherapy-induced anaemia. Relationship between variation in three fatigue-specific quality of life questionnaire scores and change in haemoglobin level. Clin Transl Oncol 2011;13:341–7
- Repetto L. Incidence and clinical impact of chemotherapy induced myelotoxicity in cancer patients: an observational retrospective survey. Crit Rev Oncol Hematol 2009;72:170–9
- Khan FA, Shukla AN, Joshi SC. Anaemia and cancer treatment: a conceptual change. Singapore Med J 2008;49:759–64
- Spaepen E, Demarteau N, Van Belle S, et al. Health economic evaluation of treating anemia in cancer patients receiving chemotherapy: a study in Belgian hospitals. Oncologist 2008;13:596–607
- Rosenbaum P, Rubin D. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41–55
- Rosenbaum P, Rubin D. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc 1984;79:516–24
- Rubin D. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997;127:757–63
- Herrett E, Thomas SL, Schoonen WM, et al. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 2010;69:4–14
- International Society for Pharmacoeconomics and Outcomes Research (ISPOR). ISPOR International Digest of Databases. http://www.ispor.org/DigestOfIntDB/CountryList.aspx. Accessed November 2, 2010
- Kirkwood B, Sterne J. Essential Medical Statistics, 2nd edn. Oxford, UK: Blackwell Science Ltd, 2003
- Euromedia S.r.l. Pagine Sanitarie [Medical Page]. http://www.informatorefarmaceutico.it/. Accessed December 10, 2010
- Vorhandene Arzneispezialitäten. Arzneispezialitaten und Wirkstoffe [Medicinal products and active ingredients]. http://www.ami–info.at/. Accessed June 21, 2010
- Ministério de Saúde. Catálogo de Aprovisionamento Público da Saúde. [Catalogue of public health supplies]. http://www.catalogo.min–saude.pt/CAPS/publico/default.asp. Accessed August 30, 2010
- Consejo General de Colegios Oficiales de Farmacéuticos. portalfarma.com - Organización Farmacéutica Colegial. http://www.portalfarma.com/. Accessed October 27, 2010
- Bundesministerium für Gesundheit. Krankenanstalten in Zahlen [Hospitals in numbers]. http://www.bmg.gv.at/cms/site/attachments/3/0/5/CH0786/CMS1226916396155/uereg_oesterreich_2008.pdf. Accessed June 21, 2010
- Ministério da Saúde. Portaria n.° 839-A/2009, de 31 de Julho. http://www.acss.min-saude.pt/Portals/0/Portaria%20839_A_2009.pdf. Accessed September 20, 2010
- Ministerio de Sanidad, Política Social e Igualdad. Registro de Altas de los Hospitales del Sistema Nacional de Salud [National Health Service, Hospital Admissions Registry]. http://www.msps.es/estadEstudios/estadisticas/cmbdhome.htm. Accessed October 27, 2010
- Conferenza delle Regioni e delle Province autonome. Tariffa unica convenzionale per le prestazioni di assistenza ospedaliera. Regole e tariffe valide per l'anno 2009 [Conventional single tariff for the supply of hospital care. Rules and rates applicable to the year 2009]. http://www.regioni.it/upload/270110TUC_ASSISTENZA_OSPEDALIERA.pdf. Accessed December 7, 2010
- Inspection Générale des Affaires Sociales, Rapport N°RM 2010-122P. Pertinence d'une intégration du montant des agents stimulant l'érythropoïèse dans les tarifs de dialyse [Relevance of integrating the amount of erythropoiesis stimulating agents in the tariffs for dialysis]. http://www.fehap.fr/DATA/16_9_2010_14_28_9_igasdialyse072010.pdf. Accessed April 8, 2011
- Eurostat. Total population and demographic events (EU-27). http://appsso.eurostat.ec.europa.eu/nui/show.do?dataset=demo_pjan&lang=en. Accessed May 28, 2010
- Belgian Cancer Registry. Number of invasive tumours per localisation and age group, males and females. http://www.kankerregister.org/. Accessed May 28, 2011
- Statistik Austria. Krebsinzidenz (Neuerkankungen pro jahr) nach lokalisationen und geschlecht [Cancer incidence (per year) by site and gender]. http://www.statistik.at/web_de/static/krebsinzidenz_neuerkankungen_pro_jahr_nach_lokalisationen_und_geschlecht_o_021806.xls. Accessed May 28, 2010
- Institut de Veille Sanitaire. [French Institute for Public Health Surveillance]. http://www.invs.sante.fr/. Accessed April 11, 2011
- Associazione Italiana dei Registri Tumori. Available at http://www.registri-tumori.it/. Accessed October 25, 2010
- Instituto Português de Oncologia do Porto Francisco Gentil. Registo Oncológico Nacional [National Oncologic Registry]. http://www.ipoporto.min-saude.pt/Downloads_HSA/IPOP/RO_Nacional_2001.pdf. Accessed 3 August 30, 2010
- Ministerio de Sanidad, Política Social e Igualdad. Conjunto Mínimo Básico de Datos - Hospitalización (CMBDH) [Minimum Basic Hospitalization Data Set]. http://pestadistico.msc.es/PEMSC25/ArbolNodos.aspx. Accessed October 27, 2010
- National Health Center for Health Statistics. International Classification of Diseases, tenth revision (ICD-10). http://www.cdc.gov/nchs/icd/icd10.htm. Accessed May 10, 2010
- Hauptverband der Sozialversicherung. Erstattungskodex - EKO [Reimbursement Code - EKO]. http://www.sozialversicherung.at/portal27/portal/esvportal/start/startWindow?action=2&p_menuid=2&p_tabid=1. Accessed May 10, 2010
- INFARMED. Legislação Farmacêutica Compilada [Compiled Pharmaceutical Legislation]. http://www.infarmed.pt/portal/page/portal/INFARMED/LEGISLACAO/LEGISLACAO_FARMACEUTICA_COMPILADA/TITULO_III/TITULO_III_CAPITULO_I/035-E_DL_176_2006_VF.pdf. Accessed August 30, 2010
- Aapro M, Link H. September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents. Oncologist 2008;13(3 Suppl):33–6
- IMS Health. IMS Multinational Integrated Data Analysis System (MIDAS) Quantum. Danbury, CT, United States, IMS Health 2011
- European Pharmaceutical Market Research Association. ATC Guidelines 2010. http://www.ephmra.org/PDF/ATC%20Guidelines%202010.pdf. Accessed June 2, 2010
- Song X, Long SR, Marder WD, et al. The impact of methodological approach on cost findings in comparison of epoetin alfa with darbepoetin alfa. Ann Pharmacother 2009;43:1203–10
- Motheral B, Brooks J, Clark MA, et al. A checklist for retrospective database studies–report of the ISPOR Task Force on Retrospective Databases. Value Health 2003;6:90–7
- Polsky D, Eremina D, Hess G, et al. The importance of clinical variables in comparative analyses using propensity-score matching: the case of ESA costs for the treatment of chemotherapy-induced anaemia. Pharmacoeconomics 2009;27:755–65
- Sax MJ. Essential steps and practical applications for database studies. J Manag Care Pharm 2005;11:S5–S8